Anna is Director Market Access and Medical Affairs at SFL.

Anna and her team develop Swiss reimbursement applications (e.g. for inclusion of pharmaceuticals in the specialties list) and support SFL’s clients with early access solutions for their products (e.g. reimbursement via Art. 71 a-d KVV). With in-depth knowledge on payor perspective and Swiss HTA criteria she also supports the triennial review of pharmaceuticals by the Federal Office of Public Health.

Leveraging her deep understanding of goal-oriented and effective communication of scientific and medical data, Anna leads medical affairs projects, preparing scientific manuscripts and educational materials, tailored to specific target audiences. She also oversees preparation of high-quality regulatory documents, such as investigator brochures, non-clinical and clinical documentation, pediatric investigation plans and scientific advice briefing booklets.

Before joining SFL, Anna conducted two years of postdoctoral research at ETH Zurich, Switzerland. Prior to that, she obtained a PhD in Cell Biology at the University of Bonn, Germany. She is confident in producing materials in English and German.